CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 113 filers reported holding CALITHERA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,000 | -51.7% | 5,810 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $29,000 | +45.0% | 5,810 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $20,000 | -35.5% | 5,810 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $31,000 | +72.2% | 5,810 | +43.5% | 0.00% | 0.0% |
| Q1 2020 | $18,000 | -21.7% | 4,050 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $23,000 | +187.5% | 4,050 | +50.7% | 0.00% | – |
| Q3 2019 | $8,000 | -20.0% | 2,688 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -44.4% | 2,688 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +63.6% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | -21.4% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | +7.7% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $13,000 | -23.5% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $17,000 | -22.7% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $22,000 | -50.0% | 2,688 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $44,000 | +10.0% | 2,688 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $40,000 | – | 2,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,290,000 | 3.82% |
| BVF INC/IL | 7,452,331 | $16,246,000 | 0.63% |
| TSP Capital Management Group, LLC | 661,600 | $1,442,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,245 | $406,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 525,667 | $1,146,000 | 0.12% |
| Parkman Healthcare Partners LLC | 100,628 | $219,000 | 0.06% |
| FEDERATED HERMES, INC. | 6,668,978 | $14,539,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 133,700 | $291,000 | 0.02% |
| Ergoteles LLC | 274,805 | $599,000 | 0.02% |
| Seelaus Asset Management LLC | 16,150 | $35,000 | 0.02% |